Clinical trial · Interventional
ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
Feasibility Study for ivWatch® in Prevention of Extravasation of Vesicants in an Oncology Setting
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Extravasation | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ivWatch | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Medical Device Usage
- description
- Patients utilize ivWatch device at time of already scheduled chemotherapy on study
- interventionNames
- Device: ivWatch
Primary outcomes (1)
- measure
- Detection of extravasation in patients wearing ivWatch
- timeFrame
- Up to 1 year
- description
- Evaluated by the ratio of number ivWatch used for vesicant therapy over the total number of vesicant therapies for study participants
Secondary outcomes (1)
- measure
- Change in number of extravasations while wearing ivWatch
- timeFrame
- Up to 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: * Patients requiring a peripheral IV for infusion of vesicant or vesicant-like agents (chemotherapy, other vesicant medications). * PIV must be inserted * Participant (or legal representative) must understand the nature of this study and verbally consent with the Research Study Information Sheet prior to receiving any study related procedure Exclusion Criteria: * Patients who are not getting a vesicant, irritant or vesicant like fluid infused. * Patients who are bruised, scarred, or tattooed in the area of the PIV. * Patients with skin integrity issues at the site of the PIV. * Patients who are on "light precautions." * Not for use in power injectors. * Not for use on mediports, implanted ports, IVAD, central lines, PICC lines. * Patients without a cancer diagnosis.
References
Publications (0)
Data not yet available